Health and Fitness Health and Fitness
Thu, June 25, 2009
[ 05:35 AM ] - Market Wire
MMR Information Systems, Inc.: MMR Information Sy .. Messaging Market With Deployment of Outbound Fax
[ 05:20 AM ] - Market Wire
Allied Healthcare: Allied Healthcare International Inc. to Join Russell 3000 Index
[ 04:00 AM ] - Market Wire
Labopharm amends debt facility agreement with Hercules
Wed, June 24, 2009
[ 03:00 PM ] - Market Wire
Harte Gold Corp.: Harte Gold Corp.: Summer Field .. am to Begin at Sugar Zone Property Hemlo, Ontario
[ 01:37 PM ] - Market Wire
UCB: Jazz Pharmaceuticals and UCB announce second .. ybate in patients with fibromyalgia meets primary
[ 06:32 AM ] - Market Wire
Amador Gold Corp.: Amador Gold Corp: Horwood Gold Project Exploration Update
Tue, June 23, 2009
[ 12:25 PM ] - Market Wire
Remedent, Inc.: Remedent Sets Fiscal Fourth Quart .. rence Call for Wednesday, July 1 at 11:00 a.m. ET
[ 08:48 AM ] - Market Wire
YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIR .. II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
[ 05:12 AM ] - Market Wire
PharmaGap Announces Agreement for the Issuance of Shares to National Research Council of Canada
[ 05:00 AM ] - Market Wire
Gamma Pharmaceuticals Inc.: Gamma Pharmaceuticals .. ach Agreement for Retail Market Coverage With Fir
Mon, June 22, 2009
[ 11:06 PM ] - Market Wire
Pharming Group N.V.: Pharming gives update on equity financing with YA Global
[ 10:11 AM ] - Market Wire
Dragon Pharma Announces Results of 2009 Annual General Meeting
[ 09:31 AM ] - Market Wire
Cancer Therapeutics, Inc.: Cancer Therapeutics Na .. d Active Investor to Its Newly Formed Advisory Bo
[ 05:44 AM ] - Market Wire
MMR Information Systems, Inc.: MMR Information Sy .. ional Patent Applications on Anti-CD20 Antibodies
[ 04:30 AM ] - Market Wire
Targeted Genetics Corporation: Targeted Genetics .. Study at University College London/Moorfields Eye
[ 04:00 AM ] - Market Wire
Eurand N.V.: FDA Extends Review Period for Eurand .. ZENPEP(TM) Pancreatic Enzyme Replacement Therapy
[ 04:00 AM ] - Market Wire
TLC Vision Corporation: TLCVision Announces Results of 2009 Annual Meeting of Shareholders
Sun, June 21, 2009
[ 11:08 PM ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Under Contract .. uction Agency for Development of Therapeutics Tar
Fri, June 19, 2009
[ 08:52 AM ] - Market Wire
AXcess News: AXcess News: Government Spending on Healthcare
[ 07:48 AM ] - Market Wire
Amarillo Biosciences, Inc.: Amarillo Biosciences .. creening Process for Influenza Study in Australia
[ 05:00 AM ] - Market Wire
MDRNA, Inc.: MDRNA, Inc. Gains Full Financial and .. ctional Control of Its Proprietary UNA Technology
[ 04:30 AM ] - Market Wire
Stellar Pharmaceuticals Inc.: Stellar Pharmaceuti .. 09 Second Quarter Revenues in Excess of One Milli
[ 04:30 AM ] - Market Wire
Anaconda Mining Inc.: Anaconda Mining Announces Private Placement Financing
[ 04:00 AM ] - Market Wire
The Medicines Company: FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Thu, June 18, 2009
[ 02:17 PM ] - Market Wire
Isotechnika Pharma announces the closing of its partnership with Paladin Labs
[ 11:27 AM ] - Market Wire
Watson Pharmaceuticals: Watson to Present at Wachovia's 19th Annual Mid-Year Equity Conference
[ 11:00 AM ] - Market Wire
IDenta Corp.: International Drug & Explosives Det .. Firm IDenta Corp. Releases Recent Sales Activity
[ 10:30 AM ] - Market Wire
Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
[ 09:25 AM ] - Market Wire
Medical Nutrition USA, Inc.: Medical Nutrition Na .. upplier by Amerinet Group Purchasing Organization
[ 08:14 AM ] - Market Wire
IMRIS CEO David Graves to Present at RBC Conference

IMRIS CEO David Graves to Present at RBC Conference


Published on 2009-06-18 08:24:15, Last Modified on 2009-06-18 08:24:33 - Market Wire
  Print publication without navigation


 WINNIPEG, June 18 /CNW/ - IMRIS Inc. (TSX: IM) ("IMRIS") today announced that David Graves, Chairman, President & CEO will present at the RBC Capital Markets' Canadian Tech and Biotech Investor Conference on June 19, 2009 at 9:20 am Eastern Time. An audio webcast of Mr. Graves' presentation will be available at [ www.imris.com ]. About IMRIS IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced imaging solutions that serve the neurosurgical, cardiovascular and stroke management markets. The Company's flagship product IMRISneuro is in use by leading neurosurgeons at world-class neuroscience centers around the globe. For more information, visit [ www.imris.com ].
For further information: Media: Michael Robbie, Director, Marketing, Tel: (204) 480-7696, Email: [ mrobbie@imris.com ]; Investors: Brad Woods, Director Investor Relations & Corporate Communications, Tel: (204) 480-7094, Email: [ bwoods@imris.com ]
Contributing Sources